nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—Potassium Canrenoate—Prednisone—chronic obstructive pulmonary disease	0.0536	0.0706	CrCrCtD
Testosterone Propionate—Potassium Canrenoate—Prednisolone—chronic obstructive pulmonary disease	0.0523	0.0689	CrCrCtD
Testosterone Propionate—Danazol—Prednisone—chronic obstructive pulmonary disease	0.0453	0.0596	CrCrCtD
Testosterone Propionate—Medrysone—Prednisolone—chronic obstructive pulmonary disease	0.0442	0.0582	CrCrCtD
Testosterone Propionate—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.0394	0.0519	CrCrCtD
Testosterone Propionate—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.0384	0.0506	CrCrCtD
Testosterone Propionate—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.0382	0.0503	CrCrCtD
Testosterone Propionate—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.0372	0.0491	CrCrCtD
Testosterone Propionate—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.037	0.0488	CrCrCtD
Testosterone Propionate—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.0361	0.0476	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.0332	0.0438	CrCrCtD
Testosterone Propionate—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0331	0.0437	CrCrCtD
Testosterone Propionate—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0324	0.0426	CrCrCtD
Testosterone Propionate—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.0324	0.0426	CrCrCtD
Testosterone Propionate—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.0323	0.0426	CrCrCtD
Testosterone Propionate—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.0315	0.0416	CrCrCtD
Testosterone Propionate—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.0308	0.0406	CrCrCtD
Testosterone Propionate—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.0301	0.0396	CrCrCtD
Testosterone Propionate—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.0281	0.037	CrCrCtD
Testosterone Propionate—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.027	0.0356	CrCrCtD
Testosterone Propionate—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0264	0.0348	CrCrCtD
Testosterone Propionate—COMT—Methylation—CYP1A2—chronic obstructive pulmonary disease	0.00415	0.0608	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00337	0.0493	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Heme degradation—HMOX1—chronic obstructive pulmonary disease	0.00308	0.0451	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.00272	0.0398	CbGpPWpGaD
Testosterone Propionate—COMT—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00259	0.038	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.00206	0.0302	CbGpPWpGaD
Testosterone Propionate—COMT—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00199	0.0291	CbGpPWpGaD
Testosterone Propionate—COMT—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00188	0.0276	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00155	0.0228	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Porphyrin metabolism—HMOX1—chronic obstructive pulmonary disease	0.00134	0.0196	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00119	0.0174	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00113	0.0165	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.00111	0.0163	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00101	0.0148	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00097	0.0142	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000948	0.0139	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000936	0.0137	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000877	0.0128	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000867	0.0127	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000769	0.0113	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000734	0.0107	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.000729	0.0107	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00069	0.0101	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000689	0.0101	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00068	0.00995	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000608	0.0089	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000607	0.00888	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000599	0.00876	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000562	0.00823	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000559	0.00818	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000558	0.00818	CbGpPWpGaD
Testosterone Propionate—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000547	0.00318	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000545	0.00317	CcSEcCtD
Testosterone Propionate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000543	0.00317	CcSEcCtD
Testosterone Propionate—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000543	0.00317	CcSEcCtD
Testosterone Propionate—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000539	0.00314	CcSEcCtD
Testosterone Propionate—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000539	0.00314	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000537	0.00313	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	0.000536	0.00785	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.00312	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000533	0.0078	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000531	0.00778	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000531	0.00778	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00053	0.00309	CcSEcCtD
Testosterone Propionate—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.00309	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000529	0.00308	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000529	0.00308	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000528	0.00774	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000525	0.00769	CbGpPWpGaD
Testosterone Propionate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000522	0.00304	CcSEcCtD
Testosterone Propionate—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000519	0.00303	CcSEcCtD
Testosterone Propionate—UGT1A1—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000519	0.0076	CbGpPWpGaD
Testosterone Propionate—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000518	0.00302	CcSEcCtD
Testosterone Propionate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000518	0.00302	CcSEcCtD
Testosterone Propionate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000518	0.00302	CcSEcCtD
Testosterone Propionate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000517	0.00301	CcSEcCtD
Testosterone Propionate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000515	0.003	CcSEcCtD
Testosterone Propionate—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000514	0.003	CcSEcCtD
Testosterone Propionate—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000514	0.003	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000513	0.00751	CbGpPWpGaD
Testosterone Propionate—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000511	0.00298	CcSEcCtD
Testosterone Propionate—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000511	0.00298	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000507	0.00743	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000507	0.00295	CcSEcCtD
Testosterone Propionate—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000504	0.00293	CcSEcCtD
Testosterone Propionate—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.00293	CcSEcCtD
Testosterone Propionate—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000502	0.00292	CcSEcCtD
Testosterone Propionate—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00292	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00291	CcSEcCtD
Testosterone Propionate—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000496	0.00289	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000491	0.00719	CbGpPWpGaD
Testosterone Propionate—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000489	0.00285	CcSEcCtD
Testosterone Propionate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000488	0.00284	CcSEcCtD
Testosterone Propionate—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000486	0.00283	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000486	0.00711	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00283	CcSEcCtD
Testosterone Propionate—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00281	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000481	0.0028	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000475	0.00277	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00276	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00276	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000471	0.00274	CcSEcCtD
Testosterone Propionate—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000467	0.00272	CcSEcCtD
Testosterone Propionate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000464	0.0027	CcSEcCtD
Testosterone Propionate—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.00268	CcSEcCtD
Testosterone Propionate—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000461	0.00268	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000448	0.00261	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00261	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000446	0.0026	CcSEcCtD
Testosterone Propionate—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00257	CcSEcCtD
Testosterone Propionate—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00257	CcSEcCtD
Testosterone Propionate—UGT1A1—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.000437	0.00639	CbGpPWpGaD
Testosterone Propionate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000435	0.00254	CcSEcCtD
Testosterone Propionate—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00253	CcSEcCtD
Testosterone Propionate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00253	CcSEcCtD
Testosterone Propionate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00253	CcSEcCtD
Testosterone Propionate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00253	CcSEcCtD
Testosterone Propionate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00253	CcSEcCtD
Testosterone Propionate—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000434	0.00253	CcSEcCtD
Testosterone Propionate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000434	0.00253	CcSEcCtD
Testosterone Propionate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000433	0.00252	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00252	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00252	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000431	0.00631	CbGpPWpGaD
Testosterone Propionate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.0025	CcSEcCtD
Testosterone Propionate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00043	0.0025	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000426	0.00624	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000426	0.00248	CcSEcCtD
Testosterone Propionate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000426	0.00248	CcSEcCtD
Testosterone Propionate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000425	0.00247	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00247	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000423	0.00246	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000421	0.00616	CbGpPWpGaD
Testosterone Propionate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000417	0.00243	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000417	0.00243	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.00243	CcSEcCtD
Testosterone Propionate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.00243	CcSEcCtD
Testosterone Propionate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00243	CcSEcCtD
Testosterone Propionate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00239	CcSEcCtD
Testosterone Propionate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00239	CcSEcCtD
Testosterone Propionate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000411	0.00239	CcSEcCtD
Testosterone Propionate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00238	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000409	0.00238	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.00238	CcSEcCtD
Testosterone Propionate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.00238	CcSEcCtD
Testosterone Propionate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00238	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00238	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000408	0.00598	CbGpPWpGaD
Testosterone Propionate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00236	CcSEcCtD
Testosterone Propionate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00236	CcSEcCtD
Testosterone Propionate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00236	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000404	0.00235	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.0059	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000402	0.00589	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000401	0.00233	CcSEcCtD
Testosterone Propionate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000397	0.00231	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000394	0.00229	CcSEcCtD
Testosterone Propionate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000394	0.00229	CcSEcCtD
Testosterone Propionate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000388	0.00226	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00225	CcSEcCtD
Testosterone Propionate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.00223	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000381	0.00558	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000381	0.00222	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00038	0.00221	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.00221	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000379	0.00554	CbGpPWpGaD
Testosterone Propionate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000377	0.0022	CcSEcCtD
Testosterone Propionate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000377	0.0022	CcSEcCtD
Testosterone Propionate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000375	0.00218	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000372	0.00217	CcSEcCtD
Testosterone Propionate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00217	CcSEcCtD
Testosterone Propionate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00217	CcSEcCtD
Testosterone Propionate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000369	0.00215	CcSEcCtD
Testosterone Propionate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000367	0.00214	CcSEcCtD
Testosterone Propionate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000366	0.00213	CcSEcCtD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000364	0.00533	CbGpPWpGaD
Testosterone Propionate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000362	0.00211	CcSEcCtD
Testosterone Propionate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000361	0.00211	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00036	0.0021	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.0021	CcSEcCtD
Testosterone Propionate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.00209	CcSEcCtD
Testosterone Propionate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00036	0.00209	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00209	CcSEcCtD
Testosterone Propionate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00208	CcSEcCtD
Testosterone Propionate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00208	CcSEcCtD
Testosterone Propionate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00207	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000356	0.00521	CbGpPWpGaD
Testosterone Propionate—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00207	CcSEcCtD
Testosterone Propionate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00206	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00205	CcSEcCtD
Testosterone Propionate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000352	0.00205	CcSEcCtD
Testosterone Propionate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00205	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000351	0.00514	CbGpPWpGaD
Testosterone Propionate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000349	0.00203	CcSEcCtD
Testosterone Propionate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000348	0.00203	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000346	0.00507	CbGpPWpGaD
Testosterone Propionate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000345	0.00201	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000345	0.00506	CbGpPWpGaD
Testosterone Propionate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000345	0.00201	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000344	0.00503	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.002	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000344	0.002	CcSEcCtD
Testosterone Propionate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000343	0.002	CcSEcCtD
Testosterone Propionate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000342	0.00199	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00199	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00199	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000341	0.00499	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00198	CcSEcCtD
Testosterone Propionate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00198	CcSEcCtD
Testosterone Propionate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00196	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000336	0.00492	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000335	0.0049	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00195	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000334	0.00195	CcSEcCtD
Testosterone Propionate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.00193	CcSEcCtD
Testosterone Propionate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000331	0.00193	CcSEcCtD
Testosterone Propionate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00192	CcSEcCtD
Testosterone Propionate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00192	CcSEcCtD
Testosterone Propionate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.00191	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000328	0.00481	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000327	0.00478	CbGpPWpGaD
Testosterone Propionate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000326	0.0019	CcSEcCtD
Testosterone Propionate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000326	0.0019	CcSEcCtD
Testosterone Propionate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.0019	CcSEcCtD
Testosterone Propionate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000325	0.00189	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00189	CcSEcCtD
Testosterone Propionate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000324	0.00189	CcSEcCtD
Testosterone Propionate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00188	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000322	0.00472	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000322	0.00471	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00188	CcSEcCtD
Testosterone Propionate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00186	CcSEcCtD
Testosterone Propionate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00186	CcSEcCtD
Testosterone Propionate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.00185	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000313	0.00458	CbGpPWpGaD
Testosterone Propionate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00182	CcSEcCtD
Testosterone Propionate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00181	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00031	0.00454	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000309	0.00452	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000307	0.0045	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00179	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00179	CcSEcCtD
Testosterone Propionate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.00179	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000306	0.00447	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000304	0.00445	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000301	0.00175	CcSEcCtD
Testosterone Propionate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00174	CcSEcCtD
Testosterone Propionate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00174	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00434	CbGpPWpGaD
Testosterone Propionate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.00172	CcSEcCtD
Testosterone Propionate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000295	0.00172	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000295	0.00432	CbGpPWpGaD
Testosterone Propionate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00171	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000293	0.00428	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00169	CcSEcCtD
Testosterone Propionate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000289	0.00168	CcSEcCtD
Testosterone Propionate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00166	CcSEcCtD
Testosterone Propionate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00166	CcSEcCtD
Testosterone Propionate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00165	CcSEcCtD
Testosterone Propionate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00163	CcSEcCtD
Testosterone Propionate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00162	CcSEcCtD
Testosterone Propionate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00161	CcSEcCtD
Testosterone Propionate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00161	CcSEcCtD
Testosterone Propionate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00157	CcSEcCtD
Testosterone Propionate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00157	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000266	0.00155	CcSEcCtD
Testosterone Propionate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00154	CcSEcCtD
Testosterone Propionate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00154	CcSEcCtD
Testosterone Propionate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000263	0.00153	CcSEcCtD
Testosterone Propionate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.00153	CcSEcCtD
Testosterone Propionate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.00153	CcSEcCtD
Testosterone Propionate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000263	0.00153	CcSEcCtD
Testosterone Propionate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00153	CcSEcCtD
Testosterone Propionate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00152	CcSEcCtD
Testosterone Propionate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00152	CcSEcCtD
Testosterone Propionate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00152	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.00026	0.0038	CbGpPWpGaD
Testosterone Propionate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00151	CcSEcCtD
Testosterone Propionate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000258	0.0015	CcSEcCtD
Testosterone Propionate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000257	0.0015	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.0015	CcSEcCtD
Testosterone Propionate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00149	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.00374	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000252	0.00369	CbGpPWpGaD
Testosterone Propionate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00146	CcSEcCtD
Testosterone Propionate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.00145	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—APIP—chronic obstructive pulmonary disease	0.000249	0.00365	CbGpPWpGaD
Testosterone Propionate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00145	CcSEcCtD
Testosterone Propionate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00145	CcSEcCtD
Testosterone Propionate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00144	CcSEcCtD
Testosterone Propionate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00144	CcSEcCtD
Testosterone Propionate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00144	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000243	0.00356	CbGpPWpGaD
Testosterone Propionate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00141	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00024	0.00351	CbGpPWpGaD
Testosterone Propionate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.00139	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000239	0.00349	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000238	0.00349	CbGpPWpGaD
Testosterone Propionate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00136	CcSEcCtD
Testosterone Propionate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.00136	CcSEcCtD
Testosterone Propionate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00135	CcSEcCtD
Testosterone Propionate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00135	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000229	0.00336	CbGpPWpGaD
Testosterone Propionate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00132	CcSEcCtD
Testosterone Propionate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00132	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00132	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000225	0.00329	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000223	0.00327	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	0.000222	0.00325	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000214	0.00313	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000213	0.00312	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000211	0.00309	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00021	0.00308	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00122	CcSEcCtD
Testosterone Propionate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00122	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000208	0.00304	CbGpPWpGaD
Testosterone Propionate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.00119	CcSEcCtD
Testosterone Propionate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00119	CcSEcCtD
Testosterone Propionate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00118	CcSEcCtD
Testosterone Propionate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00118	CcSEcCtD
Testosterone Propionate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00117	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	0.000201	0.00294	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000196	0.00287	CbGpPWpGaD
Testosterone Propionate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.00113	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000193	0.00283	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00109	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00108	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.00272	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000183	0.00268	CbGpPWpGaD
Testosterone Propionate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00106	CcSEcCtD
Testosterone Propionate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00105	CcSEcCtD
Testosterone Propionate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00101	CcSEcCtD
Testosterone Propionate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000997	CcSEcCtD
Testosterone Propionate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000997	CcSEcCtD
Testosterone Propionate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000994	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00017	0.00249	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00099	CcSEcCtD
Testosterone Propionate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000985	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000969	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000165	0.00242	CbGpPWpGaD
Testosterone Propionate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000956	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000956	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000938	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—GC—chronic obstructive pulmonary disease	0.000161	0.00235	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000929	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000158	0.00231	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.0023	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000154	0.00225	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000871	CcSEcCtD
Testosterone Propionate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00087	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000149	0.00219	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000149	0.00219	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	0.000149	0.00218	CbGpPWpGaD
Testosterone Propionate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000865	CcSEcCtD
Testosterone Propionate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000859	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000143	0.00209	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000143	0.00209	CbGpPWpGaD
Testosterone Propionate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.00083	CcSEcCtD
Testosterone Propionate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000829	CcSEcCtD
Testosterone Propionate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000824	CcSEcCtD
Testosterone Propionate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000824	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000788	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000782	CcSEcCtD
Testosterone Propionate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000782	CcSEcCtD
Testosterone Propionate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00076	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00013	0.00191	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000756	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000125	0.00183	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000704	CcSEcCtD
Testosterone Propionate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000686	CcSEcCtD
Testosterone Propionate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000676	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00167	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000654	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000109	0.00159	CbGpPWpGaD
Testosterone Propionate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000632	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000106	0.00155	CbGpPWpGaD
Testosterone Propionate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000608	CcSEcCtD
Testosterone Propionate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000603	CcSEcCtD
Testosterone Propionate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000602	CcSEcCtD
Testosterone Propionate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000599	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.89e-05	0.00145	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.77e-05	0.00143	CbGpPWpGaD
Testosterone Propionate—Nausea—Prednisone—chronic obstructive pulmonary disease	9.75e-05	0.000568	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—GC—chronic obstructive pulmonary disease	9.62e-05	0.00141	CbGpPWpGaD
Testosterone Propionate—Progesterone—CYP1A1—chronic obstructive pulmonary disease	9.25e-05	0.189	CrCbGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	9.1e-05	0.00133	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	9.07e-05	0.00133	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9e-05	0.00132	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.94e-05	0.00131	CbGpPWpGaD
Testosterone Propionate—Progesterone—CYP1A2—chronic obstructive pulmonary disease	8.91e-05	0.182	CrCbGaD
Testosterone Propionate—Norethindrone—ALB—chronic obstructive pulmonary disease	8.83e-05	0.18	CrCbGaD
Testosterone Propionate—COMT—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.77e-05	0.00128	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP1A1—chronic obstructive pulmonary disease	8.74e-05	0.178	CrCbGaD
Testosterone Propionate—COMT—Metabolism—GCLC—chronic obstructive pulmonary disease	8.67e-05	0.00127	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.4e-05	0.00123	CbGpPWpGaD
Testosterone Propionate—Methyltestosterone—ALB—chronic obstructive pulmonary disease	8.39e-05	0.171	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.31e-05	0.00122	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	8.26e-05	0.00121	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.21e-05	0.0012	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.1e-05	0.00119	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CTGF—chronic obstructive pulmonary disease	7.91e-05	0.00116	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.74e-05	0.00113	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.71e-05	0.00113	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.58e-05	0.00111	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.32e-05	0.00107	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.29e-05	0.00107	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.98e-05	0.00102	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	6.86e-05	0.001	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.8e-05	0.000995	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	6.5e-05	0.000951	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	6.39e-05	0.000936	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.08e-05	0.00089	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HMOX1—chronic obstructive pulmonary disease	6e-05	0.000878	CbGpPWpGaD
Testosterone Propionate—CYP17A1—connective tissue—chronic obstructive pulmonary disease	5.91e-05	0.164	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.82e-05	0.000853	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.74e-05	0.000841	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.59e-05	0.000818	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.35e-05	0.000784	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.3e-05	0.000776	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.26e-05	0.00077	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.2e-05	0.000761	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.07e-05	0.000743	CbGpPWpGaD
Testosterone Propionate—COMT—respiratory system—chronic obstructive pulmonary disease	4.91e-05	0.137	CbGeAlD
Testosterone Propionate—Testosterone—ALB—chronic obstructive pulmonary disease	4.87e-05	0.0994	CrCbGaD
Testosterone Propionate—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.74e-05	0.000694	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.37e-05	0.00064	CbGpPWpGaD
Testosterone Propionate—COMT—bronchus—chronic obstructive pulmonary disease	4.04e-05	0.112	CbGeAlD
Testosterone Propionate—COMT—smooth muscle tissue—chronic obstructive pulmonary disease	3.95e-05	0.11	CbGeAlD
Testosterone Propionate—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.64e-05	0.000533	CbGpPWpGaD
Testosterone Propionate—COMT—trachea—chronic obstructive pulmonary disease	3.63e-05	0.101	CbGeAlD
Testosterone Propionate—COMT—Metabolism—ALB—chronic obstructive pulmonary disease	3.6e-05	0.000527	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.59e-05	0.000526	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.45e-05	0.000505	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NOS3—chronic obstructive pulmonary disease	3.44e-05	0.000504	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.35e-05	0.00049	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.3e-05	0.000483	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.17e-05	0.000465	CbGpPWpGaD
Testosterone Propionate—AR—connective tissue—chronic obstructive pulmonary disease	3.16e-05	0.088	CbGeAlD
Testosterone Propionate—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.13e-05	0.000458	CbGpPWpGaD
Testosterone Propionate—AR—bronchus—chronic obstructive pulmonary disease	2.96e-05	0.0822	CbGeAlD
Testosterone Propionate—AR—smooth muscle tissue—chronic obstructive pulmonary disease	2.89e-05	0.0805	CbGeAlD
Testosterone Propionate—COMT—lung—chronic obstructive pulmonary disease	2.61e-05	0.0725	CbGeAlD
Testosterone Propionate—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.16e-05	0.000316	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.06e-05	0.000302	CbGpPWpGaD
Testosterone Propionate—AR—lung—chronic obstructive pulmonary disease	1.91e-05	0.0531	CbGeAlD
